Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

Article

Abstract: In the majority of cases, advanced prostate cancer responds initially to androgen deprivation therap

Palabras claves:

5-alpha-androstanedione, Abiraterone acetate, Hormonal therapy, Hormone resistance, Tumor metabolism

Autores:

Chang K.H., Li R., Papari-Zareei M., Richard J. Auchus, Sharifi N., Watumull L., Zhao Y.

Fuentes:

scopus